Skin cancer treatment options
Pro Research Analysisby 
Searched over 200M research papers
Standard Skin Cancer Treatment Options: Surgery, Radiotherapy, and Topical Therapies
Surgical excision remains the gold standard for most skin cancers, including basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma, due to its effectiveness in removing tumors and providing good cosmetic and functional outcomes. For larger or more complex cases, reconstructive techniques such as skin grafting or tissue flaps may be used. When surgery is not suitable—due to patient health, tumor location, or other factors—non-surgical options like radiotherapy and photodynamic therapy are considered, especially for superficial or smaller tumors. Topical treatments, such as 5-fluorouracil, imiquimod, and retinoids, are mainly used for superficial BCC and selected cases of SCC, offering localized therapy with fewer systemic side effects, though they are not routinely chosen for all patients 2789.
Advanced and Metastatic Skin Cancer: Targeted and Immunotherapy Approaches
For advanced or metastatic melanoma, targeted therapies and immune checkpoint inhibitors have significantly improved patient outcomes. BRAF inhibitors (vemurafenib, dabrafenib) and MEK inhibitors (trametinib, cobimetinib) are effective, especially when used in combination, leading to better overall and progression-free survival. Immune checkpoint inhibitors like ipilimumab are also increasingly used, particularly for BRAF-mutated melanoma. These therapies, while effective, can have specific side effects, such as dermatological toxicities, which require careful management .
In advanced BCC, Hedgehog pathway inhibitors are now available, targeting the molecular drivers of the disease. For advanced or metastatic SCC, immunotherapies such as cemiplimab (a PD-1 inhibitor) are approved, and other agents like pembrolizumab, ipilimumab, and nivolumab are under investigation. These treatments offer new hope for patients who cannot undergo surgery or have resistant disease, though drug resistance and tolerability remain challenges 47.
Emerging and Future Therapies: Nanotechnology and Targeted Drug Delivery
Recent advances in nanotechnology are transforming skin cancer treatment. Nanocarrier-based drug delivery systems, including liposomes, niosomes, ethosomes, and nanoemulsions, allow for targeted delivery of chemotherapy and other agents directly to tumor sites. This approach increases drug concentration at the tumor, reduces systemic toxicity, and can overcome drug resistance. Smart delivery systems, microneedle-assisted delivery, and 3D-printed scaffolds are also being explored to further enhance precision and minimize side effects. These technologies are especially promising for patients with multidrug-resistant cancers or those who cannot tolerate conventional therapies 35610.
Combination and Personalized Therapies
Combination therapies—using multiple drugs or integrating surgery with systemic treatments—are increasingly common, as they can improve outcomes and reduce the risk of recurrence. Personalized treatment strategies, based on tumor genetics and patient characteristics, are becoming more feasible with advances in molecular diagnostics and targeted therapies. This individualized approach aims to maximize effectiveness while minimizing unnecessary side effects and interventions 156.
Conclusion
Skin cancer treatment options have expanded significantly beyond traditional surgery and radiotherapy. For early-stage disease, surgery remains the mainstay, with non-surgical and topical therapies as alternatives in select cases. For advanced or metastatic cancers, targeted therapies, immunotherapies, and innovative nanotechnology-based approaches are improving survival and quality of life. Ongoing research continues to refine these options, aiming for more personalized, effective, and less toxic treatments for all types of skin cancer.
Sources and full results
Most relevant research papers on this topic